University of Michigan
Ann Arbor, Michigan, 48109, United States
Location status: Recruiting
Location contact
Laura Stchur, MSW
CONTACT
Sophia Hovakimian
CONTACT
Stephan Taylor, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06050070
The purpose of this study is to develop a technique called real time fMRI neurofeedback.
This technique uses a regular MRI scanner, except that special software allows the researchers to measure activity in participants brain, using fMRI, and then give information, in the form of a feedback signal, which indicates brain activity in real time, while in the MRI scanner. The larger goal of this study is to develop ways to help people, including those with depression, better regulate brain activity. The researchers think that this may be helpful in managing psychiatric symptoms.
This study design has three phases, however, only two phases (phase 2 and 3) are considered to be a clinical trial. Phase 2 (part 2) was registered and is NCT05934604. This is the phase 3 (part 3) for this project and is funded by the National Institutes of Health.
Interested in participating?
Request Info18 year–55 year
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Location status: Recruiting
Laura Stchur, MSW
CONTACT
Sophia Hovakimian
CONTACT
Stephan Taylor, MD
PRINCIPAL_INVESTIGATOR
Part 3/Phase 3 study hypothesis are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During the second fMRI, the study will introduce the real time fMRI neurofeedback part of the study. This is where subjects will use the activity from the brain to control the size of the circular pattern viewed in the first two visits. This is real time fMRI because the pattern will change, in real time, based on what the fMRI scan measures in the brain. Participants will be encouraged to make the circular pattern grow in size, just by thinking about it.
In order to see if the neurofeedback is really helping change the size of the circular pattern, the study team will have a control condition. In this controlled condition, subjects will see the circular pattern change, and the study team will ask participants to try and increase the size, except that the changing size will not actually be determined by your brain activity. This a called a sham condition because the feedback signal is not real.
During the second fMRI, the study will introduce the real time fMRI neurofeedback part of the study. This is where subjects will use the activity from the brain to control the size of the circular pattern viewed in the first two visits. This is real time fMRI because the pattern will change, in real time, based on what the fMRI scan measures in the brain. Participants will be encouraged to make the circular pattern grow in size, just by thinking about it.
Time frame: Approximately 40 minutes (during MRI)
Using standard pre-processing pipelines, the general linear model, convolved with the hemodynamic response function, will be used to predict change in BOLD signal for the contrast of the active compared to the passive conditions. Z-transformed t-statistics will be corrected for multiple comparisons in the region of interest (salience network)
Time frame: Approximately 40 minutes (during MRI)
Same processing as outcome measure 2, except the contrast of active>passive will itself be contrasted within the session (baseline compared to transfer run)
Contact information is provided by the study sponsor or research team.
Laura Stchur, MSW
CONTACT
Sophia Hovakimian
CONTACT
University of Michigan
Other
Targeting Large-scale Networks in Depression With Real-time fMRI Neurofeedback
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03437928
Depressive Disorder, Depressive Disorder, Major
Dallas, Texas, United States
View Trial DetailsNCT07592689
Depressive Disorder, Depressive Disorder, Major
Gilbert, Arizona, United States
View Trial DetailsNCT06462196
Analgesics, Anesthetics
Bethesda, Maryland, United States
View Trial DetailsNCT00018057
Anxiety Disorders, Depressive Disorder
Bethesda, Maryland, United States
View Trial Details